These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 7986586

  • 41. Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type 1 glycoprotein 120 by N-linked oligosaccharides in the V1 region.
    Losman B, Bolmstedt A, Schønning K, Björndal A, Westin C, Fenyö EM, Olofsson S.
    AIDS Res Hum Retroviruses; 2001 Jul 20; 17(11):1067-76. PubMed ID: 11485624
    [Abstract] [Full Text] [Related]

  • 42. CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage.
    Xiao L, Owen SM, Goldman I, Lal AA, deJong JJ, Goudsmit J, Lal RB.
    Virology; 1998 Jan 05; 240(1):83-92. PubMed ID: 9448692
    [Abstract] [Full Text] [Related]

  • 43. Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread.
    Toohey K, Wehrly K, Nishio J, Perryman S, Chesebro B.
    Virology; 1995 Oct 20; 213(1):70-9. PubMed ID: 7483281
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
    Lusso P, Earl PL, Sironi F, Santoro F, Ripamonti C, Scarlatti G, Longhi R, Berger EA, Burastero SE.
    J Virol; 2005 Jun 20; 79(11):6957-68. PubMed ID: 15890935
    [Abstract] [Full Text] [Related]

  • 46. Conserved V3 loop sequences and transmission of human immunodeficiency virus type 1.
    Shpaer EG, Delwart EL, Kuiken CL, Goudsmit J, Bachmann MH, Mullins JI.
    AIDS Res Hum Retroviruses; 1994 Dec 20; 10(12):1679-84. PubMed ID: 7888227
    [Abstract] [Full Text] [Related]

  • 47. Effect of mutations in the V3 loop of HIV-1 gp120 on infectivity and susceptibility to proteolytic cleavage.
    Schulz TF, Reeves JD, Hoad JG, Tailor C, Stephens P, Clements G, Ortlepp S, Page KA, Moore JP, Weiss RA.
    AIDS Res Hum Retroviruses; 1993 Feb 20; 9(2):159-66. PubMed ID: 8457383
    [Abstract] [Full Text] [Related]

  • 48. Tryptase TL2 in the membrane of human T4+ lymphocytes is a novel binding protein of the V3 domain of HIV-1 envelope glycoprotein gp 120.
    Kido H, Fukutomi A, Katunuma N.
    FEBS Lett; 1991 Jul 29; 286(1-2):233-6. PubMed ID: 1677898
    [Abstract] [Full Text] [Related]

  • 49. In vivo sequence variability of human immunodeficiency virus type 1 envelope gp120: association of V2 extension with slow disease progression.
    Shioda T, Oka S, Xin X, Liu H, Harukuni R, Kurotani A, Fukushima M, Hasan MK, Shiino T, Takebe Y, Iwamoto A, Nagai Y.
    J Virol; 1997 Jul 29; 71(7):4871-81. PubMed ID: 9188549
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Human immunodeficiency virus type 1 gp120 envelope characteristics associated with disease progression differ in family members infected with genetically similar viruses.
    Baan E, van der Sluis RM, Bakker ME, Bekker V, Pajkrt D, Jurriaans S, Kuijpers TW, Berkhout B, Wolthers KC, Paxton WA, Pollakis G.
    J Gen Virol; 2013 Jan 29; 94(Pt 1):20-29. PubMed ID: 23015744
    [Abstract] [Full Text] [Related]

  • 52. Protein and DNA-sequence homologies between the V3-loop of human immunodeficiency virus type I envelope protein gp120 and immunoglobulin variable regions.
    Metlas R, Veljkovic V, Paladini RD, Pongor S.
    Biochem Biophys Res Commun; 1991 Sep 16; 179(2):1056-62. PubMed ID: 1898386
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. The envelope glycoprotein of HIV-1 may have incorporated the CD4 binding site from HLA-DQ beta 1.
    Brinkworth RI.
    Life Sci; 1989 Sep 16; 45(20):iii-ix. PubMed ID: 2557504
    [Abstract] [Full Text] [Related]

  • 55. HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasispecies.
    Epstein LG, Kuiken C, Blumberg BM, Hartman S, Sharer LR, Clement M, Goudsmit J.
    Virology; 1991 Feb 16; 180(2):583-90. PubMed ID: 1989385
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Antiviral effects of milk proteins: acylation results in polyanionic compounds with potent activity against human immunodeficiency virus types 1 and 2 in vitro.
    Swart PJ, Kuipers ME, Smit C, Pauwels R, deBéthune MP, de Clercq E, Meijer DK, Huisman JG.
    AIDS Res Hum Retroviruses; 1996 Jun 10; 12(9):769-75. PubMed ID: 8738428
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.